Question follow-through · 126417
Menopause: Hormone Replacement Therapy
To ask the Secretary of State for Health and Social Care, what steps the Government is taking to update NHS prescribing guidance for menopause, including first-line use of transdermal oestrogen gel and access to testosterone for women with confirmed low b
About this written question
A written question asks a government minister for information in writing. Parliament publishes the question and any answer.
- Answering body
- Department of Health and Social Care
- Tabled
- 10 Apr 2026
- Target answer date
- 14 Apr 2026
- Answer
- 16 Apr 2026 · 6 calendar days after tabling
Elapsed calendar days describe the record timeline, not whether Parliament considers an answer on time.
More questions by this MP on Health and care
- Care Workers · 14 May 2026
- Fractures: Health Services · 15 May 2026
- Palliative Care · 15 May 2026
- Palliative Care · 15 May 2026
- Meningitis: Vaccination · 29 May 2026
Shared topic keywords suggest a connection; they do not establish a follow-up.
Votes on this topic
- Terminally Ill Adults (End of Life) Bill: Second Reading · 11 Sept 2026
- Health Bill: Report Stage: Amendment 1 · 8 Sept 2026
- Health Bill: Report Stage: New Clause 143 · 8 Sept 2026
These Commons divisions share a topic label. The question did not necessarily lead to a vote.
Recorded timeline
10 Apr 2026
Question tabled
To ask the Secretary of State for Health and Social Care, what steps the Government is taking to update NHS prescribing guidance for menopause, including first-line use of transdermal oestrogen gel and access to testosterone for women with confirmed low b
14 Apr 2026
Target answer date
Date supplied by the official written-questions record.
16 Apr 2026
Answer published
The Government is committed to improving women’s health outcomes, including through better awareness and support for menopause, and we will continue to work with NHS England and the National Institute for Health and Care Excellence (NICE) to ensure patien...
Official data retrieved 28 Sept 2026.
Later records
Possible follow-up questions
Strong links require the same MP, department and exact heading. Other same-department questions are shown as unreviewed candidates, not as confirmed follow-ups. No debate link is asserted unless a stable source relationship exists.
Care Workers
14 May 2026 · To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential merits of a funded domestic adult social care workforce plan, in the context of levels of (a) demand for NHS services and (b) recent trends in healthy l
Fractures: Health Services
15 May 2026 · To ask the Secretary of State for Health and Social Care, what assessment he has made of the adequacy of the progress towards improving consistency of access to Fracture Liaison Services; and what steps he is taking to support the development and implemen
Palliative Care
15 May 2026 · To ask the Secretary of State for Health and Social Care, what steps his Department is taking to ensure that local integration care boards implement the modern service framework for palliative and end of life care.
Palliative Care
15 May 2026 · To ask the Secretary of State for Health and Social Care, when his Department plans to publish the interim statement on the modern service framework for palliative and end of life care.
Meningitis: Vaccination
29 May 2026 · To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the potential merits of expanding access to the MenB vaccine to cohorts who missed vaccination following its introduction into the routine schedule.
Metachromatic Leukodystrophy
1 Jun 2026 · To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential merits of adding metachromatic leukodystrophy (MLD) to the NHS newborn blood spot screening programme.
Metachromatic Leukodystrophy
1 Jun 2026 · To ask the Secretary of State for Health and Social Care, how many children diagnosed with metachromatic leukodystrophy since the approval of gene therapy treatment have been assessed as ineligible for treatment because diagnosis occurred after symptoms d
Labyrinthitis: Health Services
3 Jun 2026 · To ask the Secretary of State for Health and Social Care, what steps his Department is taking to improve (a) awareness and (b) training among GPs on the (i) diagnosis and (ii) management of balance disorders.
Labyrinthitis: Health Services
3 Jun 2026 · To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the adequacy of the availability of specialist diagnostic and treatment services for balance disorders.
Labyrinthitis: Health Services
3 Jun 2026 · To ask the Secretary of State for Health and Social Care, what guidance his Department provides to NHS organisations on signposting patients with balance disorders to relevant voluntary sector support organisations.
NHS: Databases
8 Jun 2026 · To ask the Secretary of State for Health and Social Care, what safeguards are in place within the NHS Federated Data Platform to help ensure that external contractors and third-party suppliers are not able to access identifiable patient data.
NHS: Data processing
8 Jun 2026 · To ask the Secretary of State for Health and Social Care, whether the Section 254 direction under the Health and Social Care Act 2012 will be published and laid before Parliament for full scrutiny.